Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Company Data

Name Zhengye Biotechnology Holding Limited - Ordinary Shares

Company Zhengye Biotechnology Holding Limited

Symbol ZYBT

Website https://www.jlzybio.com

Primary Exchange

NASDAQ

ISIN KYG989MS1016

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Songlin Song

Market Capitalization 274 Mio

Country China

Currency USD

Employees 0,3 T

Address No.1 Lianmeng Road, 132101 Jilin

IPO Date 2025-01-07

Ticker Symbols

Name	Symbol
NASDAQ	ZYBT

More Shares

Investors who hold Zhengye Biotechnology Holding Limited - Ordinary Shares also have the following shares in their portfolio:

ABU DHABI 20/70 MTN REGS Bond

BERKSH.HATHA 21/41 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog